Drugs / Domiphen
last change Oct 2022 re-read 9 days ago

Domiphen

Small molecule

Developed for
vulvovaginal candidiasis
Investigated by
Aesculape CRO Belgium BV

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04813822 Sep 2021 → May 2022 vulvovaginal candidiasis Aesculape CRO Belgium BV Unknown No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Domiphen ClinicalTrials.gov intervention name — accepted as the source's own label NCT04813822 ↗
Known as Bromure de domiphene ChEMBL registry synonym — accepted as the source's own label CHEMBL1187011 ↗
Known as Bromuro de domifeno ChEMBL registry synonym — accepted as the source's own label CHEMBL1187011 ↗
Known as Domiphen Bromide “Miconazole Nitrate 2% + Domiphen Bromide Low Dose” NCT04813822 ↗
Known as Domiphen cation ChEMBL registry synonym — accepted as the source's own label CHEMBL1187011 ↗
Known as Domiphen ion ChEMBL registry synonym — accepted as the source's own label CHEMBL1187011 ↗
Known as NSC-39415 ChEMBL registry synonym — accepted as the source's own label CHEMBL1187011 ↗
Known as Oradol ChEMBL registry synonym — accepted as the source's own label CHEMBL1187011 ↗
Known as Phenododecinium ChEMBL registry synonym — accepted as the source's own label CHEMBL1187011 ↗
Known as Phenododecinium bromide ChEMBL registry synonym — accepted as the source's own label CHEMBL1187011 ↗
Modality Small molecule — CHEMBL1187011 ↗
Route Other “administered intravaginally” NCT04813822 ↗